XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Rental income $ 16,743,231 $ 17,203,310
Fees and other income 892,383 560,971
Total revenue 17,635,614 17,764,281
Costs and expenses:    
Rental operating costs 5,962,918 5,841,396
General and administrative 6,790,432 6,163,816
Depreciation and amortization 5,425,739 5,465,015
Impairment of goodwill and real estate assets 3,247,097 0
Total costs and expenses 21,426,186 17,470,227
Other income (expense):    
Interest and other income, net 20,878 21,075
Gain on sales of real estate, net 3,240,200 5,079,912
Gain on deconsolidation of SPAC (see footnote 9) 40,321,483 0
Income tax (expense) benefit 335,780 (1,215,873)
Total other income, net 16,968,098 1,191,474
Net income 13,177,526 1,485,528
Less: Income attributable to noncontrolling interests (3,031,080) (3,612,647)
Net income (loss) attributable to Presidio Property Trust, Inc. stockholders 10,146,446 (2,127,119)
Less: Preferred Stock Series D dividends (2,118,846) (2,152,740)
Less: Series A Warrant dividend 0 (2,456,512)
Net income (loss) attributable to Presidio Property Trust, Inc. common stockholders $ 8,027,600 $ (6,736,371)
Net income (loss) per share attributable to Presidio Property Trust, Inc. common stockholders:    
Basic & Diluted (in dollars per share) $ 0.68 $ (0.57)
Weighted average number of common shares outstanding - basic & dilutive (in shares) 11,847,814 11,753,041
All Other Than Conduit [Member]    
Other income (expense):    
Gain (loss) on sale of marketable securities, net $ 1,414,420 $ 2,018,847
Conduit Pharmaceuticals Inc [Member]    
Other income (expense):    
Gain (loss) on sale of marketable securities, net (23,359,774) 0
Mortgage Notes [Member]    
Other income (expense):    
Interest expense $ (5,004,889) $ (4,712,487)